MINK THERAPEUTICS INC (INKT) Stock Analyst Earnings Estimates
NASDAQ:INKT - Nasdaq - US6036931029 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 690K | N/A -100.00% | 36.148M | 71.808M 98.65% | 105.26M 46.59% | 140.25M 33.24% | |||||||
| EBITDA YoY % growth | -22.75M | N/A 52.79% | N/A -72.53% | N/A -66.38% | N/A 26.32% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -22.79M | N/A 52.61% | -33.572M -72.31% | -32.043M -66.31% | -23.413M 25.94% | -11.076M 51.68% | -14.92M -34.70% | -17.57M -17.77% | -20.586M -17.16% | 20.298M 198.60% | 34.68M 70.85% | 63.24M 82.35% | |
| Operating Margin | -3,302.90% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -56.95% | 28.27% | 32.95% | 45.09% | |
| EPS YoY % growth | N/A | N/A | -1.20 | -0.85 30.85% | -0.66 20.48% | -0.27 58.79% | -0.28 -1.25% | -0.29 -5.56% | -0.16 46.21% | 0.24 256.56% | 0.42 70.83% | 0.77 82.93% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 68.13% | -0.06 44.36% | -0.07 5.29% | -0.07 -42.80% | -0.08 -60.00% | -0.07 -16.67% | -0.07 -7.69% | -0.07 | -0.06 25.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.143M 61.03% | -3.625M 5.35% | -4.303M -40.13% | -5.101M -170.67% | -6.034M -181.54% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.05 66.67% | -0.08 | 0.03 | 38.73% |
| Q2 2024 Q2Q % growth | -0.07 61.11% | -0.10 | 0.03 | 31.37% |
| Q1 2024 Q2Q % growth | -0.11 35.29% | -0.16 | 0.05 | 29.67% |
| Q4 2023 Q2Q % growth | -0.16 30.43% | -0.16 | 0.00 | -2.30% |
| Q3 2023 Q2Q % growth | -0.15 21.05% | -0.19 | 0.04 | 19.42% |
| Q2 2023 Q2Q % growth | -0.18 | -0.20 | 0.02 | 10.65% |
| Q1 2023 Q2Q % growth | -0.17 26.09% | -0.24 | 0.07 | 29.82% |
| Q4 2022 Q2Q % growth | -0.23 -27.78% | -0.21 | -0.02 | -7.38% |
| Q3 2022 Q2Q % growth | -0.19 67.80% | -0.24 | 0.05 | 19.88% |
| Q2 2022 Q2Q % growth | -0.18 | -0.24 | 0.06 | 26.47% |
| Q1 2022 Q2Q % growth | -0.23 | -0.21 | -0.02 | -9.11% |
| Q4 2021 Q2Q % growth | -0.18 | -0.42 | 0.24 | 56.96% |
| Q3 2021 Q2Q % growth | -0.59 | -0.21 | -0.38 | -182.16% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 64.29% | 0% | 21.57% |
| Revenue | N/A | N/A | N/A | N/A |